Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Leukemia 17Leukemia, Lymphocytic, Chronic, B-Cell 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Mantle-Cell 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Myeloid, Acute 10Breast Neoplasms 10Multiple Myeloma 9Lymphoma, Non-Hodgkin 9Congenital Abnormalities 9Burkitt Lymphoma 9Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 8Lymphoma 7Head and Neck Neoplasms 7Colorectal Neoplasms 7Colonic Neoplasms 7Waldenstrom Macroglobulinemia 6Rectal Neoplasms 6Myeloproliferative Disorders 6Melanoma 6Lymphoma, T-Cell, Cutaneous 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Hairy Cell 6Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 5Sezary Syndrome 5

Interventions

Gemcitabine 58Cisplatin 41Capecitabine 27Oxaliplatin 25durvalumab 16Fluorouracil 16Leucovorin 15S 1 (combination) 11lenvatinib 10Nivolumab 10Irinotecan 10pembrolizumab 8apatinib 8Immune Checkpoint Inhibitors 7130-nm albumin-bound paclitaxel 7tremelimumab 6Bevacizumab 6camrelizumab 5Trastuzumab 5Drug Therapy 5Blood Specimen Collection 5Albumin-Bound Paclitaxel 5tislelizumab 4irinotecan sucrosofate 4Taxes 4Liquid Biopsy 4Folfox protocol 4toripalimab 3surufatinib 3gemcitabine-oxaliplatin regimen 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Biliary Tract Neoplasms × Polymerase Chain Reaction × Clear all
NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

Peking Union Medical College Hospital

Unknown
450 enrolled
GastrointestinalOther neoplasm

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡